Wajeha Hamoudi
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Phosphoproteomic profiling reveals reversal of dysregulated kinase signaling by nitric oxide inhibition in the Shank3 mouse model of autism.
Journal: Scientific reports
Published: October 31, 2025
Nitric Oxide-Mediated S-Nitrosylation of TSC2 Drives mTOR dysregulation across Shank3 and Cntnap2 Models of Autism Spectrum Disorder.
Journal: Molecular psychiatry
Published: June 05, 2025
Shared early molecular mechanisms revealed in P301S and 5xFAD Alzheimer's disease mouse models.
Journal: Translational psychiatry
Published: September 29, 2024
The Role of Thioredoxin System in Shank3 Mouse Model of Autism.
Journal: Journal of molecular neuroscience : MN
Published: August 23, 2024
The multifaceted role of mitochondria in autism spectrum disorder.
Journal: Molecular psychiatry
Published: March 10, 2024
Mutations associated with autism lead to similar synaptic and behavioral alterations in both sexes of male and female mouse brain.
Journal: Scientific reports
Published: September 10, 2023
Nitric Oxide Synthase Inhibition Prevents Cell Proliferation in Glioblastoma.
Journal: Journal of molecular neuroscience : MN
Published: September 07, 2023
Effects of extended-release 7-nitroindazole gel formulation treatment on the behavior of Shank3 mouse model of autism.
Journal: Nitric oxide : biology and chemistry
Published: August 20, 2023
The NO Answer for Autism Spectrum Disorder.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 07, 2022
A cross-talk between nitric oxide and the glutamatergic system in a Shank3 mouse model of autism.
Journal: Free radical biology & medicine
Published: March 27, 2022
Regional Differences in S-Nitrosylation in the Cortex, Striatum, and Hippocampus of Juvenile Male Mice.
Journal: Journal of molecular neuroscience : MN
Published: November 30, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026